Toresson Linda, Suchodolski Jan S, Spillmann Thomas, Lopes Bruna C, Shih Johnathan, Steiner Jörg M, Pilla Rachel
Evidensia Specialist Animal Hospital Helsingborg, 254 66 Helsingborg, Sweden.
Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, 00014 Helsinki, Finland.
Animals (Basel). 2023 Apr 17;13(8):1378. doi: 10.3390/ani13081378.
Cobalamin deficiency is a common sequela of chronic enteropathies (CE) in dogs. Studies comparing the intestinal microbiome of CE dogs with cobalamin deficiency to those that are normocobalaminemic are lacking. Therefore, our aim was to describe the fecal microbiome in a prospective, comparative study evaluating 29 dogs with CE and cobalamin deficiency, 18 dogs with CE and normocobalaminemia, and 10 healthy control dogs. Dogs with cobalamin deficiency were also analyzed after oral or parenteral cobalamin supplementation. Overall microbiome composition (beta diversity) at baseline was significantly different in CE dogs with cobalamin deficiency when compared to those with normocobalaminemia ( = 0.001, R = 0.257) and to healthy controls ( = 0.001, R = 0.363). Abundances of Firmicutes and Actinobacteria were significantly increased (q = 0.010 and 0.049), while those of Bacteroidetes and Fusobacteria were significantly decreased (q = 0.002 and 0.014) in CE dogs with cobalamin deficiency when compared to healthy controls. Overall microbiome composition in follow-up samples remained significantly different after 3 months in both dogs receiving parenteral (R = 0.420, = 0.013) or oral cobalamin supplementation (R = 0.251, = 0.007). Because cobalamin supplementation, in combination with appropriate therapy, failed to restore the microbiome composition in the dogs in our study, cobalamin is unlikely to be the cause of those microbiome changes but rather an indicator of differences in underlying pathophysiology that do not influence clinical severity but result in a significant aggravation of dysbiosis.
钴胺素缺乏是犬类慢性肠病(CE)的常见后遗症。目前尚缺乏比较钴胺素缺乏的CE犬与钴胺素水平正常的CE犬肠道微生物群的研究。因此,我们的目的是在一项前瞻性比较研究中描述粪便微生物群,该研究评估了29只患有CE且钴胺素缺乏的犬、18只患有CE且钴胺素水平正常的犬以及10只健康对照犬。对钴胺素缺乏的犬在口服或胃肠外补充钴胺素后也进行了分析。与钴胺素水平正常的犬(P = 0.001,R = 0.257)和健康对照犬(P = 0.001,R = 0.363)相比,基线时钴胺素缺乏的CE犬的总体微生物群组成(β多样性)存在显著差异。与健康对照犬相比,钴胺素缺乏的CE犬中厚壁菌门和放线菌门的丰度显著增加(q = 0.010和0.049),而拟杆菌门和梭杆菌门的丰度显著降低(q = 0.002和0.014)。在接受胃肠外(R = 0.420,P = 0.013)或口服钴胺素补充的犬中,随访样本中的总体微生物群组成在3个月后仍存在显著差异(R = 0.251,P = 0.007)。由于在我们研究中,钴胺素补充与适当治疗相结合未能恢复犬的微生物群组成,因此钴胺素不太可能是这些微生物群变化的原因,而更可能是潜在病理生理学差异的一个指标,这些差异不影响临床严重程度,但会导致生态失调显著加重。